期刊文献+

中国隐匿性肝性脑病临床诊治专家共识意见 被引量:6

Chinese consensus on clinical diagnosis and management of covert hepatic encephalopathy
原文传递
导出
摘要 隐匿性肝性脑病(CHE)是肝性脑病的重要类型。有别于显性肝性脑病(OHE),CHE患者无定向力障碍、扑翼样震颤等明显临床表现,但存在神经心理学和(或)神经生理学异常,部分患者可出现轻微认知障碍、欣快或焦虑,注意力和计算能力下降。CHE不仅易进展为OHE,还严重影响患者驾驶能力、精细操作能力和健康相关生活质量,增加意外伤害风险,加重家庭和社会负担,缩短肝硬化患者生存期。为进一步提高对CHE的认识,规范CHE诊治,中华医学会消化病学分会组织国内相关领域专家,参考近期国内外相关指南和共识,总结近年来相关领域的研究成果,结合我国实际情况,制定本共识意见。本共识意见就CHE的定义,流行病学,病因、诱因和发病机制,临床表现,诊断和治疗,以及预后和慢病管理形成19项陈述条款,以期为规范国内CHE的诊治提供指导。 Covert hepatic encephalopathy(CHE)is one of the important entities of hepatic encephalopathy.In contrast to patients with overt hepatic encephalopathy(OHE),patients with CHE have no readily identifiable clinical symptoms and signs such as disorientation and asterixis,but have neurocognitive abnormalities detected by neuropsychological and neurophysiological tests.Some patients may experience cognitive impairment,euphoria or anxiety,decreased attention and calculation abilities.CHE is not only prone to develop into OHE,but also has harmful impacts on driving fitness,fine operation ability,and employment,impairs the health-related quality of life,and increases the risk of accidents,resulting in worse financial status and a heavy burden to the family and society and the reduction of the survival of cirrhotic patients.To further deepen the understanding of CHE and standardize its clinical diagnosis and treatment,the Chinese Society of Gastroenterology,Chinese Medical Association organized experts to establish a consensus based on the updated relevant guidelines,experts′consensus,research advance on the diagnosis and treatment of CHE,and clinical practice in China.This consensus contains 19 statements on the definition,epidemiology,etiology,precipitating factors,pathogenesis,clinical manifestations,diagnosis,treatment,prognosis,and chronic disease management of CHE.We aimed to provide the best available evidence to guide clinical practice in the diagnosis and management of patients with CHE.
作者 中华医学会消化病学分会肝胆疾病学组 谢渭芬 唐承薇 刘玉兰 王吉耀 Hepatobiliary Disease Group,Chinese Society of Gastroenterology,Chinese Medical Association;Xie Weifen;Tang Chengwei;Liu Yulan;Wang Jiyao(不详;Department of Gastroenterology,the Second Affiliated Hospital of Naval Medical University(Shanghai Changzheng Hospital),Shanghai 200003,China;Department of Gastroenterology,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Gastroenterology,People′s Hospital,Peking University,Beijing 100044,China;Department of Gastroenterology and Hepatology,Zhongshan Hospital,Fudan University,Shanghai 200032,China)
出处 《中华消化杂志》 CAS CSCD 北大核心 2023年第11期721-736,共16页 Chinese Journal of Digestion
基金 国家重点研发计(2023YFC2507500)。
关键词 隐匿性肝性脑病 诊断 治疗 共识 Covert hepatic encephalopathy Diagnosis Therapy Consensus
  • 相关文献

参考文献12

二级参考文献88

共引文献340

同被引文献42

  • 1胡晔,赵桂鸣,张英平.微生态制剂治疗肝性脑病的研究进展[J].中国肝脏病杂志(电子版),2009,1(1):50-54. 被引量:10
  • 2邢卉春.肝性脑病诊断治疗专家共识[J].中国肝脏病杂志(电子版),2009,1(2):46-55. 被引量:39
  • 3Ji-Yao Wang,Ning-Ping Zhang,Bao-Rong Chi,Yu-Qing Mi,Li-Na Meng,Ying-Di Liu,Jiang-Bin Wang,Hai-Xing Jiang,Jin-Hui Yang,Yun Xu,Xiao Li,Jian-Ming Xu,Guo Zhang,Xin-Min Zhou,Yu-Zheng Zhuge,De-An Tian,Jin Ye,Yu-Lan Liu.Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China[J].World Journal of Gastroenterology,2013,19(30):4984-4991. 被引量:70
  • 4许培钦,马秀现,叶学祥,冯留顺,党晓卫,赵永福,张水军,唐哲,赵龙栓,卢秀波.布-加综合征外科治疗20年经验总结(附1360例报告)[J].中国实用外科杂志,2004,24(9):543-545. 被引量:33
  • 5hartmann I J, Groeneweg M, Ouerojc, et al. The prognostic signifi- cance of subclinical hepatic encephalopathy [J]. Am J Gastroen- terol,2000,95:2029 - 2034.
  • 6Das A, Dhiman RK, Saraswat VA, et al. Prevalence and natural his- tory of subclinical hepatic encephalopathy in cirrhosis [ J]. J Gas- troenterol Hepatol,2007,16:531 - 535.
  • 7Gupta A, Dhiman RK, Kumari S, et al. Role of small intestinal bac- terial overgrowth and delayed gastrointestinal transit time in cirrhot- ic patients with minimal hepatic encephalopathy [J]. J Hepatol, 2010,53:849 - 855.
  • 8Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy [J]. Nat Rev Gastroenterol Hepatol, 2010,7:515 - 525.
  • 9Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health - related quality of life in patients with cirrho- sis who have minimal hepatic encephalopathy [ J]. Hepatology,2007,45:549 - 559.
  • 10Sharma P, Sharma BC, Puri V, et al. An open - label randomized controlled trial of laetulose and probioties in the treatment of mini- real hepatic eneephalopathy [J]. Eur J Gastroenterol Hepatol, 2008,20:506 - 511.

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部